Genpharmasec Complete Financial Statements

In FY2025, Genpharmasec (GENPHARMA) reported revenue ₹33 Cr, net profit ₹-1 Cr and EPS ₹-0.02, with a net profit margin of -3.0% and ROE of -1.5%. Full financial statements from FY2023 to FY2025 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Genpharmasec share price today.

3 Years of Data
2025 - 2023

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -3.03% 2025 data
Operating Margin -1.00% 2025 data
Return on Assets -1.25% 2025 data
Return on Equity -1.54% 2025 data

Balance Sheet Ratios

Current Ratio 5.40 2025 data
Debt to Equity 1.23 2025 data
Equity Ratio 81.25% 2025 data
Asset Turnover 0.41 2025 data

GENPHARMA Revenue, Net Profit & EBITDA — Year-on-Year Growth

GENPHARMA YoY (Sept 2024 vs Sept 2025) — revenue +371.4%, net profit -200.0%, EBITDA -100.0%, expenses +450.0%.

Revenue Growth
+371.4%
Year-over-Year
Net Profit Growth
-200.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
+450.0%
Year-over-Year
Assets Growth
+12.7%
Year-over-Year
Liabilities Growth
+12.7%
Year-over-Year
Operating Cash Flow Growth
+200.0%
Year-over-Year
Investing Cash Flow Growth
+46.4%
Year-over-Year
Financing Cash Flow Growth
-102.1%
Year-over-Year

GENPHARMA Income Statement — Revenue, EBITDA & Net Profit

Genpharmasec revenue ₹33 Cr, EBITDA ₹0 Cr, net profit ₹-1 Cr, EPS ₹-0.02 (2025) — net profit margin -3.0%. Explore GENPHARMA true value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023
Revenue 33 15 13 7 11 6 9 8 6 6 7
Expenses 33 15 11 6 10 5 8 8 6 6 6
EBITDA 0 0 2 1 0 1 2 0 0 0 0
Operating Profit Margin % -1.00% -7.00% 8.00% 2.00% 0.00% 4.00% 9.00% -1.00% 3.00% 0.00% 0.00%
Depreciation 1 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -1 0 1 1 0 1 1 0 0 0 0
Tax 0 0 0 0 0 0 1 0 -1 0 0
Net Profit -1 0 1 1 0 0 1 0 1 0 0
Earnings Per Share (₹) -0.02 -0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.04 0.00 0.00

GENPHARMA Balance Sheet — Assets, Liabilities & Shareholders' Equity

GENPHARMA total assets ₹80 Cr, total equity ₹65 Cr, total liabilities ₹80 Cr (2025) — ROE -1.5%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023
ASSETS
Total Assets 80 71 20
Current Assets 27 41 19
Fixed Assets 8 1 0
Capital Work in Progress 0 0 0
Investments 19 19 1
Other Assets 54 51 19
LIABILITIES
Total Liabilities 80 71 20
Current Liabilities 5 4 3
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 65 65 15
Share Capital 55 55 28
Reserves & Surplus 10 9 -12

GENPHARMA Cash Flow Statement — Operating, Investing & Financing

Genpharmasec operating cash flow ₹3 Cr, investing ₹-15 Cr, financing ₹-1 Cr, net cash flow ₹-14 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023
Operating Activities 3 -3 -3
Investing Activities -15 -28 0
Financing Activities -1 48 3
Net Cash Flow -14 17 0